A detailed history of Raymond James Financial Inc transactions in Natera, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 650,849 shares of NTRA stock, worth $133 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
650,849
Previous 832,482 21.82%
Holding current value
$133 Million
Previous $141 Million 25.51%
% of portfolio
0.04%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$133.66 - $181.11 $24.3 Million - $32.9 Million
-181,633 Reduced 21.82%
650,849 $105 Million
Q2 2025

Aug 14, 2025

SELL
$132.23 - $171.87 $10.7 Million - $13.9 Million
-81,139 Reduced 8.88%
832,482 $141 Million
Q1 2025

May 13, 2025

SELL
$132.63 - $177.0 $1.5 Million - $2 Million
-11,322 Reduced 1.22%
913,621 $129 Million
Q4 2024

Feb 06, 2025

BUY
$117.67 - $174.0 $109 Million - $161 Million
924,943 New
924,943 $146 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $19.8B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Raymond James Financial Inc Portfolio

Follow Raymond James Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Inc with notifications on news.